Author: Benharouga, Mohamed; Haardt, Martin; Kartner, Norbert; Lukacs, Gergely L.
Title: Cooh-Terminal Truncations Promote Proteasome-Dependent Degradation of Mature Cystic Fibrosis Transmembrane Conductance Regulator from Post-Golgi Compartments Document date: 2001_5_28
ID: q3agdeju_6
Snippet: The majority of CF-associated point mutations, including the most common, ⌬ F508 CFTR, impair biosynthetic processing by disrupting posttranslational folding at the ER (Welsh and Smith, 1993; Zielenski and Tsui, 1995; Riordan, 1999) . Recently, we have identified a mechanistically distinct category of mutation, caused by premature terminations and frameshift mutations in the CF gene (Haardt et al., 1999) . Although the ER processing of these CO.....
Document: The majority of CF-associated point mutations, including the most common, ⌬ F508 CFTR, impair biosynthetic processing by disrupting posttranslational folding at the ER (Welsh and Smith, 1993; Zielenski and Tsui, 1995; Riordan, 1999) . Recently, we have identified a mechanistically distinct category of mutation, caused by premature terminations and frameshift mutations in the CF gene (Haardt et al., 1999) . Although the ER processing of these COOHterminally truncated CFTR variants missing their last 70-82 amino acid residues (T70 and T82 CFTR) is similar to that of the wt form, the biological half-life of the complexglycosylated mutants is sixfold shorter than their wt counterpart (Haardt et al., 1999) . Although the proteolytic elimination mechanism of the processing mutants entrapped in the ER has been extensively studied (Welsh and Smith, 1993; Kopito, 1999; Riordan, 1999) , the cellular processes responsible for the short residence time of the truncated CFTR in post-Golgi compartments remained obscure.
Search related documents:
Co phrase search for related documents- amino acid and CFTR variant: 1
- amino acid and ER processing: 1, 2
- amino acid and extensively study: 1
- amino acid and frameshift mutation: 1, 2, 3
- amino acid and obscure remain: 1, 2
- amino acid and point mutation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35
- amino acid and premature termination: 1, 2, 3, 4, 5, 6
- amino acid and processing mutant: 1, 2
- amino acid and residence time: 1
- amino acid and wt form: 1
- amino acid residue and cellular process: 1, 2
- amino acid residue and point mutation: 1, 2, 3
- biosynthetic processing and ER processing: 1
- biosynthetic processing and frameshift mutation: 1, 2
- biosynthetic processing and residence time: 1
- biosynthetic processing and wt counterpart: 1, 2
Co phrase search for related documents, hyperlinks ordered by date